DC Chemicals supplies: Mavoglurant (AFQ 056),cas: 543906-09-8,Catalog: DC7681,In stock.
Contact: website:www.dcchemicals.com,
sales@dcchemicals.com,order@dcchemicals.com,info@dcchemicals.com,
Tel: +86-21-58447131;Fax:+86-21-61643258；
Product name: Mavoglurant (AFQ 056), Synonyms: UNII-GT0I9SV4F6; AFQ056; Mavoglurant; SureCN989279; GT0I9SV4F6; CHEMBL3087515; AFQ 056; AFQ-056, cas: 543906-09-8, MW: 313.39082, Molecule Formula: C19H23NO3
Mavoglurant (AFQ 056), cas: 543906-09-8, UNII-GT0I9SV4F6; AFQ056; Mavoglurant; SureCN989279; GT0I9SV4F6; CHEMBL3087515; AFQ 056; AFQ-056, Purity:>98%. Best Price and high quality from DC Chemicals. Mavoglurant (AFQ056) is an experimental drug candidate for the treatment of fragile X syndrome.It exerts its effect as an antagonist of the metabotropic glutamate receptor 5 (mGLU5).
Mavoglurant (AFQ056) is an experimental drug candidate For the treatment of fragile X syndrome.[1] It exerts its effect as an antagonist of the metabotropic glutamate receptor 5 (mGLU5).
Mavoglurant is under development by Novartis and is currently in Phase II and Phase III clinical trials. Phase IIb/III dose finding and evaluation trials For fragile X-syndrome have been discontinued by the end of 2014. Otherwise, it would have been the first drug to treat the underlying disorder instead of the symptoms of fragile X syndrome.
Mavoglurant is also in Phase II clinical trials For Levodopa-induced dyskinesia.
In 2007, Norvartis had conducted a clinical study to assess its ability of reducing cigarette smoking, but no results had been published up till now.
Currently Novartis is conducting a clinical trial with this drug on obsessive compulsive disorder.
Novartis discontinued development of mavoglurant For fragile X syndrome in April 2014 following disappointing trial results.For the detailed information of Mavoglurant (AFQ 056), the solubility of Mavoglurant (AFQ 056) in water, the solubility of Mavoglurant (AFQ 056) in DMSO, the solubility of Mavoglurant (AFQ 056) in PBS buffer, the animal experiment (test) of Mavoglurant (AFQ 056), the cell expriment (test) of Mavoglurant (AFQ 056), the in vivo, in vitro and clinical trial test of Mavoglurant (AFQ 056), the EC50, IC50,and Affinity of Mavoglurant (AFQ 056), Please contact DC Chemicals.
没有评论:
发表评论